A Multicentre, Comparative, Two-arm, Parallel-group, Double-blind, Randomized Phase III Study to Assess Immunogenicity and Safety of LBVH0101 (Haemophilus Influenzae Type b Tetanus Toxoid Conjugate Vaccine) Compared With Hiberix Vaccine in Healthy Infants at Two, Four and Six Months of Age.

Trial Profile

A Multicentre, Comparative, Two-arm, Parallel-group, Double-blind, Randomized Phase III Study to Assess Immunogenicity and Safety of LBVH0101 (Haemophilus Influenzae Type b Tetanus Toxoid Conjugate Vaccine) Compared With Hiberix Vaccine in Healthy Infants at Two, Four and Six Months of Age.

Completed
Phase of Trial: Phase III

Latest Information Update: 12 Jan 2012

At a glance

  • Drugs Hib vaccine conjugate (Euhib) (Primary)
  • Indications Haemophilus infections
  • Focus Pharmacodynamics; Registrational
  • Sponsors LG Life Sciences
  • Most Recent Events

    • 12 Jan 2012 Results published in Vaccine.
    • 25 Dec 2009 New trial record
    • 25 Dec 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top